The next day I started with the medications and the therapy. And I also started reckoning with this terrible question: If I'm not the tough person who could have made it through a concentration camp, then who am I? And if I have to take medication, is that medication making me more fully myself, or is it making me someone else? And how do I feel about it if it's making me someone else?
As clinicians, we routinely make critical decisions for our patients with depression. Because of the uncertainty of factors that affect diagnosis and treatment, clinicians may find an objective, quick measurement tool helpful. Measurementbased care (MBC) provides specific and objective information on which to base clinical decisions and should therefore enhance quality of care and treatment outcomes. (1-3) MBC rests on these assumptions. * Compared with general questions that are typically asked during a patient evaluation, specific measurements (administered by clinicians or self-reported by patients) provide more accurate information on which to establish a diagnosis, assess treatment outcomes, and modify treatments. * Patients who complete these measurement tests will better understand their disorder and treatment effects, which will enable them to better manage their depression. * Medical records that include the results of specific measurements will assist subsequent clinicians in understanding the results of prior treatments. * The routine use of the same measurements in practice and clinical research studies will help clinicians translate research findings into their own practices. * For most outpatients with depression, self-report methods are available that are free and that take little time and effort. Diagnostic measurements Researchers have used criterion-based diagnostic methods for years. After DSM-III was introduced in 1980, the Structured Clinical Interviews for DSM-III (SCID) (and later for DSMIV) were developed to obtain lifetime diagnoses. (4,5) Briefer structured interviews were then developed, including the Mini-International Neuropsychiatric Interview (MINI), which assesses only current diagnoses, and the MINI-Plus, which elicits information about current and past diagnoses. (6-8) The MINI takes 30 to 40 minutes to administer, while the MINI-Plus may take up to 60 minutes. Studies have shown that structured or semistructured interviews provide more accurate diagnoses than typical practice. For example, clinically rendered diagnoses were compared with those made based on SCID results. (9) Major diagnostic differences were found in 40% of outpatients with clinical diagnoses of schizophrenia or bipolar or major depressive disorders. In addition, when clinicians were provided with a diagnosis that was determined using SCID, they changed the chart diagnosis in a substantial proportion of cases and prescribed fewer medications. (10) Symptom measurements Once a diagnosis has been made and therapy has been initiated, the regimen must often be modified because of intolerance, adverse effects, or other less-than-desirable symptomatic outcomes. Medication and somatic therapies are typically aimed at treating symptoms, but psychotherapy and disease self-management may also address other aspects of treatment (eg, medication adherence, social/occupational function, self-esteem). The Texas Medication Algorithm Project (TMAP) and the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) studies showed that diligent assessment of symptoms and adverse effects enhances outcomes. (11-14) The goal of therapy for depression is symptom remission and, ultimately, sustained remission and functional recovery. (15) Most patients require more than 1 treatment revision (eg, altered dosage, treatment, or delivery). When implementing guideline-driven or evidencebased care, initial treatment is continued until remission or maximal symptom improvement is obtained or until the patient cannot tolerate the regimen. Thereafter, the dosage or type of treatment may...
Abstract DESCRIPTION: Update of the 2009 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for major depressive disorder (MDD) in children and adolescents. METHODS: The USPSTF reviewed the evidence on the benefits and harms of screening; the accuracy of primary care-feasible screening tests; and the benefits and harms of treatment with psychotherapy, medications, and collaborative care models in patients aged 7 to 18 years. POPULATION: This recommendation applies to children and adolescents aged 18 years or younger who do not have a diagnosis of MDD. RECOMMENDATION: The USPSTF recommends screening for MDD in adolescents aged 12 to 18 years. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for MDD in children aged 11 years or younger. (I statement).
And then the anxiety set in. If you told me that I'd have to be depressed for the next month, I would say, "As long I know it'll be over in November, I can do it." But if you said to me, "You have to have acute anxiety for the next month," I would rather slit my wrist than go through it. It was the feeling all the time like that feeling you have if you're walking and you slip or trip and the ground is rushing up at you, but instead of lasting half a second, the way that does, it lasted for six months. It's a sensation of being afraid all the time but not even knowing what it is that you're afraid of. And it was at that point that I began to think that it was just too painful to be alive, and that the only reason not to kill oneself was so as not to hurt other people.
But in 1994, three years later, I found myself losing interest in almost everything. I didn't want to do any of the things I had previously wanted to do, and I didn't know why. The opposite of depression is not happiness, but vitality. And it was vitality that seemed to seep away from me in that moment. Everything there was to do seemed like too much work. I would come home and I would see the red light flashing on my answering machine, and instead of being thrilled to hear from my friends, I would think, "What a lot of people that is to have to call back." Or I would decide I should have lunch, and then I would think, but I'd have to get the food out and put it on a plate and cut it up and chew it and swallow it, and it felt to me like the Stations of the Cross.
And one of the things that often gets lost in discussions of depression is that you know it's ridiculous. You know it's ridiculous while you're experiencing it. You know that most people manage to listen to their messages and eat lunch and organize themselves to take a shower and go out the front door and that it's not a big deal, and yet you are nonetheless in its grip and you are unable to figure out any way around it. And so I began to feel myself doing less and thinking less and feeling less. It was a kind of nullity.
经颅磁刺激技术(transcranial magnetic stimulation,TMS)即以磁信号刺激颅脑神经方式达到神经功能改善目的。TMS在1985应用于临床治疗,随着技术的发展与革新,出现具有连续可调功能的重复TMS(repetitive transcranial magnetic stimulation,rTMS),并在临床精神病、神经疾病及康复领域获得越来越多的认可。低频和高频rTMS均能有效治疗抑郁症,二者效果相当,但前者耐受性更好,适应人群更广泛,故目前抑郁症治疗中主要采用低频rTMS。2016年美国临床经颅刺激学会发布的TMS治疗重度抑郁症共识[22]指出,每日左前额TMS治疗急性期抑郁症患者安全有效。该共识认为,对于临床诊断符合DSM-5定义的抑郁症,单次发作或复发性抑郁症、抗抑郁症药物治疗效果不佳或不耐受的患者,应考虑单独或合并TMS治疗。TMS在急性期及急性期后治疗中均有良好效果,并且急性期后持续TMS治疗可降低抑郁症复发风险。


這裡二十幾歲,但是和抑鬱打交道也是十幾年了。也經歷過許多不同階段,甚至對意思告訴我的“痊癒 這裡二十幾歲,但是和抑鬱打交道也是十幾年了。也經歷過許多不同階段,甚至對意思告訴我的“痊癒”抱懷疑態度。 因為自己從小也接觸了這方面,在診所的時候也閱讀過一些書,有人認為抑鬱症不是一種「痊癒」,祂更像某個階段的情緒,比如“痊癒”後遇到更大的打擊,如果心態和觀念發生變化,好像還有另外一種堅強熬過去。 也有人覺得抑鬱是沒由來的,好像沒有抑鬱的理由,但就是喪失了繼續生活的樂趣,其實我覺得許多抑鬱的人多多少少都會自求發出求救信號。 我自己而言停藥多年,時而抑鬱,已經習慣了和抑鬱做朋友,反復的掙扎麻木,反復的激奮和追求,今天可以多開心就可以有多難過。 但對自身症狀的分析,潛意識裡抗拒諮詢和吃藥,該懂的都懂,也許我腦袋裡希望自己以這種抑鬱來“放鬆自己”。 搞笑的是自己會坐樓頂邊緣來折磨自己,當改變想法回地面的時候又會有一種鬆了口氣的感覺來理解自己。計畫永遠都在變,明天要去死明天要活著,但是明天的明天也不看醫生不吃藥,醫院的表能做出別人想要的不同的結果,催眠自己藥貴諮詢費貴來逃避,又會覺得自己還繼續搞笑的活著呢。 我覺得這個症狀太複杂,沒有固定的治療方式,每個人都是不同的。有的人需要看諮詢有的人不需要,藥的作用除了帶來心裡的某些慰藉和生理的壓制,真的覺得不會有多少人喜歡吃藥,因為吃藥還會帶來一種潛意識觀「我有病」。 一些重藥對精神分裂者和重度抑鬱者會短期內有效的作用,所有人的主觀意識都是「治病先治命」,當然也祇有活著才有可能治療。大概 十年前自己吃的一些藥副作用比較大,我確實腦袋少折騰很多,身體也是。因為我昏昏沉沉,反應遲鈍,記憶力變差,身體無力疲憊,根本沒有多的精力去思考問題就算是自殘和死亡。大概是因為這種原因我對藥也產生了一種陰影,覺得它不是在救我,而是對我的症狀更大的摧殘。我時刻希望自己正常生活,又抗拒正常生活的我為什麼要吃藥,為什麼要難受,人本身就是矛盾的。 也是十幾年前我們當地的一個老師,確診中度抑鬱,大家覺得她平時是一個很積極陽光的人,在這個小城市最多覺得一個人孤僻,什麼抑鬱症大部分人沒聽說過覺得矯情。 這個老師也覺得多放鬆多走走就好了,因為她自己也不瞭解抑鬱症,其實已經產生一種自愈的情緒,而醫院這邊為了幫她好起來給她開了少量的藥,她一下子就崩潰了,沒過多久在她們居民樓八樓跳樓自殺了。 我們諮詢師和我們説起這個老師的時候,覺得她是突然覺得原來自己有這麼嚴重,需要到吃藥的地步,心裡開始告訴自己「原來我有病」,也去查了好多抑鬱的事情,越瞭解越抑鬱,也預約過她們諮詢師但沒有後續,後來就聽到自殺的事。 因為離我當時的家也挺近的,路過看到她家人在她逝去的地方跪著燒紙錢痛哭,也和別人搭話想不通為什麼,覺得也不是身體上的絕症為什麼好端端一個人就想不開了,我們不是她無法明白她內心最後到底是怎麼掙扎的。 以及很小就發現自己的一共“共情”情緒,現在都想用“共鬱”來形容。可以説這是人的基本感官感受,比如看了喜劇會笑,看了恐怖片會怕,而我看了一些電影比如「霸王別姬」會更加抑鬱,並且不斷的去瞭解影片中的角色的情緒,並深深的影響了我,我在很久很久中都難以走出來。 遇到好的人事物真的可以是良藥,也可以是毒藥。最常見是親情友情愛情,特別友情愛情,遇到好的朋友會樂觀很多,遇到喜歡的戀人會積極很多,而一旦被這種信任的人傷害,痛苦是翻了好幾倍的,一下子這個人就不好了的感覺,比如我現在。 持續跟帖,説了自己遇到的一些事和理解,好像無法幫上樓主,但是覺得樓主開的貼很有意義,謝謝。 ... 饲养员童S

(到底敏感词都是啥啊。。。) 在我没有意识到抑郁症控制我思想的时候(下面会详细讲),我曾经 (到底敏感词都是啥啊。。。) 在我没有意识到抑郁症控制我思想的时候(下面会详细讲),我曾经跟我的心理医生这样说过,我不会告诉你我的计划,我的计划是我寻求 解 脱的最后手段,我为什么要告诉你,为什么让你去破坏它?我来找你不是为了不死,如果只是不死的话,你把我一直绑? 着就好了,我找你是求你让我不痛苦。治标 不治本没有用。这样的痛苦换谁也难活下去。。。 关于抑郁症控制 思想。因为关注这一块,所以我从一开始就知道抑郁症是疾病,也及时意识到自己状态不对果断去就医,但当时我不知道的是,它会对我的想法造成影响。它让我感觉我永远走不出去。一时的痛苦不可怕,无尽的痛苦才最可怕,没有希望才最可怕。如果一个人觉得自己再怎么做都是徒劳,就会很容易地放弃努力放弃挣扎了。 很多心理医生都会对患者说这样一句话: 你的感觉不等于事实。 你的感觉不等于事实。 你的感觉不等于事实。 对于抑郁症患者,这一点请一定记住。当你觉得永无 天日的时候,提醒自己,这是抑郁症在作怪,是它在撒谎。 我的心理医生一直跟我讲,这些痛苦都是暂时的,她说哪怕现在就像在隧道里,你要相信你能走出去。于是我赌了一把。我当时对自己说,我再给自己一年的时间,如果再没有任何转变,我就用我自己的办法结束痛苦。现在回过头来看,这其实是一个非常冒险的做法,因为即使医生们相信抑郁症可治愈,但因为每个人不一样,没有人知道抑郁症多久能痊愈,即便是有疗效也没有人知道疗效会不会立竿见影,也许很快,也许要很久。多年也是有可能的。 再一个就是关于药物治疗有没有用。我的体会是药物对重症治疗比中度或轻微抑郁治疗的效果快得多。但关键是找对药。我觉得自己无比幸运,遇到了一个经验丰富的心理医生,心理医生又给推荐了一个非常负责的精神科医生。在剂量和选药上医生都无比谨慎,我前后试了很多种才找到了适合自己的一种。 还是那句话,没人是为了死而死的。很多人是没有办法了才用死来结束活着的痛苦。如果人们知道不管多久,这种痛苦终究会结束,黑暗有尽头。我相信大部分人都会心怀希望地抗争下去。 我莽撞地拿自己的生命赌了一把,幸运的在医生们的帮助下赌赢了。 如今走过那一劫,非常庆幸自己等了,才得以在今天有机会做着自己喜欢的事情,为未来努力。 最后还有一个小小心愿,希望有朝一日能帮助更多的人。 ... Miss Williame

经颅磁刺激技术(transcranial magnetic stimulation,TMS)即以磁信号刺激颅脑神经方式达到神经功能改善目的。TMS在1985应用于临床治疗,随着技术的发展与革新,出现具有连续可调功能的重复TMS(repetitive transcranial magnetic stimulation,rTMS),并在临床精神病、神经疾病及康复领域获得越来越多的认可。低频和高频rTMS均能有效治疗抑郁症,二者效果相当,但前者耐受性更好,适应人群更广泛,故目前抑郁症治疗中主要采用低频rTMS。2016年美国临床经颅刺激学会发布的TMS治疗重度抑郁症共识[22]指出,每日左前额TMS治疗急性期抑郁症患者安全有效。该共识认为,对于临床诊断符合DSM-5定义的抑郁症,单次发作或复发性抑郁症、抗抑郁症药物治疗效果不佳或不耐受的患者,应考虑单独或合并TMS治疗。TMS在急性期及急性期后治疗中均有良好效果,并且急性期后持续TMS治疗可降低抑郁症复发风险。
English: Help Someone with Depression, Français: aider une personne en dépression, Italiano: Aiutare chi Soffre di Depressione, Español: ayudar a alguien con depresión, Deutsch: Einer andere Person mit ihren Depressionen helfen, Português: Ajudar Alguém com Depressão, Nederlands: Iemand met een depressie helpen, Русский: помочь человеку справиться с депрессией, Čeština: Jak pomoci člověku, který trpí depresí, Bahasa Indonesia: Menolong Orang yang Mengalami Depresi, Tiếng Việt: Giúp đỡ Người Mắc Bệnh Trầm cảm, العربية: مساعدة من يعاني من الاكتئاب
4.1.1 急性期 急性期治疗原则是迅速控制症状,尽可能达到临床治愈。药物治疗是中重度抑郁急性期治疗首选,可考虑联合物理治疗、心理治疗及替代与补充治疗等。在抑郁危重状态或多种治疗效果不佳时可紧急采取电休克治疗(electroconvulsive therapy,ECT)。急性期治疗,特别是首发抑郁症的初始治疗,药物的合理选择十分重要,关系到疾病转归及后续治疗预后。合理选药可根据Preskorn教授提出 “STEPS”原则综合考虑,即用药的安全性(safety)、耐受性(tolerance)、疗效(efficacy)、价格(payment)、服用简便性(simplicity)。确定治疗药物后,需根据患者病情、年龄及耐受性,以适当速度增加药物剂量。抗抑郁症药物起效一般较慢,常需2~4周。治疗期间建议定期以量表形式对病情及治疗效果进行评估。如果经4~8周足量治疗,症状仍无明显改善,需要进行重新评估并相应调整治疗计划。可以考虑联合心理治疗、物理治疗,或者更换其他治疗药物。药物更换可以是同类药物内(如从一种SSRIs到另一种SSRIs),或不同类药物间(如从SSRIs到SNRIs)。抗抑郁症药物通常作用机制相近,不良反应常常类似,且药物间相互作用大,故不建议多药联合治疗。例如,5-HT综合征是SSRIs并发症,可在单独或合并使用SSRIs或与其他具有5-HT能特性药物联用时发生,故后两种药物合用情况应尽量避免[9]。由于MAOIs需要进行严格的饮食药物限制,有潜在致命性的药物间相互作用,用药应更加谨慎。